verified SJR 6,788 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Elsevier Ltd

workspace_premium Q1 — Pulmonary and Respiratory Medicine lock_open Open Access

The Lancet Respiratory Medicine

The Lancet Respiratory Medicine launched in March 2013 as the fourth Lancet specialty journal following in the footsteps of The Lancet Oncology, The Lancet Neurology, and The Lancet Infectious Diseases. The journal offers the same unique fast track experience offered by its siste...

ISSN: 2213-2600

Publisher: Elsevier Ltd

Category: Pulmonary and Respiratory Medicine

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

6,788 Q1

H-index 197

Acceptance rate pie_chart

22% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

4.598 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

6,788

H-index

197

Docs (year)

231

Docs 3y

909

Total refs

4114

Cites 3y

8335

Citable 3y

410

Cites/Doc 2y

9.38

Ref/Doc

17.81

Immediate OA

4598 €

Embargoed OA

0 €

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Basic deficiencies noted in COPD care in England and Wales

Xpert MTB/RIF to diagnose tuberculosis in children

Dorothy Stopford Price

DNA methylation in childhood asthma: an epigenome-wide meta-analysis

Death is not a lullaby

COPD staging with GOLD: the newer the better?

Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data

Changes in GOLD: today and tomorrow

Canberra Government to demolish asbestos-contaminated homes

Can the internet help economically disadvantaged smokers?

Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries

Breaking down barriers to lung health

SHOW MORE ARTICLES

Blood testing in the diagnosis of pulmonary alveolar proteinosis -Authors' reply

2015 American Thoracic Society International Conference

Atul Malhotra: president-elect of the American Thoracic Society

Asthma control: learning from Finland's success

Asthma 2014: from monoclonals to the microbiome

ARDS: promising insights for a challenging syndrome

ALK and ROS1 non-small-cell lung cancer: two molecular subgroups sensitive to targeted therapy

Air pollution, health, and human rights

Ageing society and allergies challenge German health care

Adherence in cystic fibrosis; care teams need to change first

Adenotonsillectomy improves asthma outcomes in children

A patient's perspective on treatment

FAQs

The Lancet Respiratory Medicine has an SJR of 6,788 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 4598 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for The Lancet Respiratory Medicine is 22%.

The Lancet Respiratory Medicine

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of The Lancet Respiratory Medicine?

What is the APC / publication cost?

What is the acceptance rate?